The Potential Rise in the Price of Neuronetics Inc (STIM) following insiders activity

Neuronetics Inc’s recently made public that its EVP, GC, CCO and CS MACAN WILLIAM ANDREW unloaded Company’s shares for reported $17716.0 on Feb 29 ’24. In the deal valued at $2.94 per share,6,026 shares were sold. As a result of this transaction, MACAN WILLIAM ANDREW now holds 389,333 shares worth roughly $1.83 million.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Then, MACAN WILLIAM ANDREW sold 22,377 shares, generating $70,711 in total proceeds. Upon selling the shares at $3.16, the EVP, GC, CCO and CS now owns 395,359 shares.

Before that, Furlong Stephen sold 3,985 shares. Neuronetics Inc shares valued at $12,593 were divested by the EVP, CFO and Treasurer at a price of $3.16 per share. As a result of the transaction, Furlong Stephen now holds 483,776 shares, worth roughly $2.28 million.

William Blair downgraded its Neuronetics Inc [STIM] rating to a Mkt perform from a an Outperform in a research note published recently. A number of analysts have revised their coverage, including BTIG Research’s analysts, who decreased its forecast for the stock in mid October from “a Buy” to “a Neutral”. William Blair also remained covering STIM and has increased its forecast on January 22, 2021 with a “an Outperform” recommendation from previously “Mkt perform” rating. BTIG Research started covering the stock on February 06, 2020. It rated STIM as “a Buy”.

Price Performance Review of STIM

On Monday, Neuronetics Inc [NASDAQ:STIM] saw its stock jump 11.35% to $4.71. Over the last five days, the stock has gained 24.27%. Neuronetics Inc shares have risen nearly 62.41% since the year began. Nevertheless, the stocks have risen 60.75% over the past one year. While a 52-week high of $4.44 was reached on 03/25/24, a 52-week low of $1.03 was recorded on 01/04/24. SMA at 50 days reached $3.53, while 200 days put it at $2.23. A total of 0.96 million shares were traded, compared to the trading of 0.16 million shares in the previous session.

Levels Of Support And Resistance For STIM Stock

The 24-hour chart illustrates a support level at 4.44, which if violated will result in even more drops to 4.16. On the upside, there is a resistance level at 4.99. A further resistance level may holdings at 5.26. The Relative Strength Index (RSI) on the 14-day chart is 69.55, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.24, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 16.32%. Stochastics %K at 86.98% indicates the stock is a selling.

How much short interest is there in Neuronetics Inc?

A steep rise in short interest was recorded in Neuronetics Inc stocks on Feb 29, 2024, dropping by -0.17 million shares to a total of 0.15 million shares. Yahoo Finance data shows the prior-month short interest on Jan 31, 2024 was 0.32 million shares. There was a decline of -110.74%, which implies that there is a negative sentiment for the stock. In spite of short shares comprising just 0.60% of the overall stock float, the days-to-cover ratio (short ratio) fell to 0.99.

The most recent change occurred on July 24, 2018 when Canaccord Genuity began covering the stock and recommended ‘”a Buy”‘ rating.

Most Popular